Sep 25-26, 2025

Guangzhou・China

English 简体中文
CONFERENCE TOPICS

  • Stem cells
  • Regenerative Medicine
  • MSCs vs iPSCs
  • Organoids and exosomes
  • Anti-aging
  • Regulatory challenges

  • Application for treatment of more            common diseases
  • Tackling immunogenicity
  • Rare diseases & orphan drugs
  • Novel gene AAV delivery systems
  • Oncolytic Virus

  • Automation & closed systems
  • Scaling up to commercial level
  • Keeping costs low
  • Decentralized and Point-of-care                           manufacturing
  • Quality Control
  • CMC, Analytics and Safety

  • Immunotherapy for solid tumours
  • In vivo CART
  • TILs
  • Car-NK
  • mRNA based TCR-T

  • Safety and ethical considerations
  • CRISPR/Cas9
  • Clinical trials development

RNA Therapy

  • siRNA
  • microRNA
  • ASO
  • mRNA Pharma and Vaccine

  • Ensuring clinical success
  • Clinical and nursing perspectives
  • Transitioning from clinical to commercial
  • Cold Chain
Biotech Start up showcase

If you are interested in roadshow presentation, please contact:


Mr.Jeff Lim

Jeff.lim@xperiobio.com


Gene Editing
Gene Therapy
Clincal Trials
Stem Cell
Cell Therapy
CGT Manufacturing
Star up showcase
GEOGRAFIC BREAKDOWN
Great Bay Region
East China
Rest of China
Oversea
43%
28%
25%
4%
Plenary Session：Global Vision, China Speed

Track 1：Next Gen Cell Therapy-Autoimmune and 

in vivo CART Breakthrough

Track 11：Next Milestone of RNA therapy-Translational Medicine, Clinical trials and Venture Overseas

Track 9：Stem Cell and Regenerative Medicine- Health Management, Exosomes and Anti-aging

Track 6：Gene Therapy and Delivery Technology-the road of innovation for gene therapy: from lab to commercialization

Sep 26

Morning

Sep 25

Morning

Sep 25

Afternoon

Sep 26

Afternoon

Track 10：Next Milestone of RNA therapy-Technology Iterations and Technique Optimization 

Track 3：Next Gen Cell Therapy-Outbreaking Progress in Solid/Hematologic Tumer 

Agenda at a glance

Track 4：Gene Therapy and Delivery Technology- CNS，Rare Diseases and Ophthalmology  

Track 2：Next Gen Cell Therapy-Technique Challenges and QC Key Points

Track 5：Gene Therapy and Delivery Technology-Gene Editing Progress

Track 7：Stem Cell and Regenerative medicine-Breakthrough and Transition

Track 8：Stem Cell and Regenerative Medicine-iPSC and Clinical Transformation

Track 12：Next Milestone of RNA Therapy-Unlock Future Vaccine Innovation